Introducing SMN lacking exon 7 (SMNΔ7)—the predominant mRNA produced by SMN2—into a severe SMA mouse genetic background partially ameliorates the SMA phenotype and these mice die at 14–15 days13. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.